PolarityTE is biotech company focused on improving the lives of patients through developing and commercializing regenerative tissue products and biomaterials that enable the patient to regenerate their own tissue.
Total raised: $22.5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.05.2024 | - | $22.5M | - |
Mentions in press and media 9
| Date | Title | Description |
| 22.05.2024 | PolarityTE Raises $22.5M Financing | PolarityTE, a Salt Lake City, UT-based clinical-stage biotechnology company developing regenerative tissue products, raised $22.5M in funding. Backers included institutional investors and current shareholders. In addition, the company close... |
| 18.01.2022 | PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication | SALT LAKE CITY, Jan. 18, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today announced that the U.S. Food and Drug Administration (FDA) has approved it... |
| 20.12.2021 | PolarityTE Announces Submission of Complete Response to FDA's Clinical Hold Correspondence for SkinTE® Investigational New Drug Application | SALT LAKE CITY, Dec. 20, 2021 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today announced that it has submitted its complete response to the U.S. Food and ... |
| 10.11.2021 | PolarityTE to host conference call and webcast today, November 10, 2021, at 8:30 a.m. ET - Form 8-K | PolarityTE to host conference call and webcast today, November 10, 2021, at 8:30 a.m. ET SALT LAKE CITY, November 10, 2021 - PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, to... |
| 10.11.2021 | PolarityTE Reports Third Quarter Financial Results and Provides Business Update | SALT LAKE CITY, Nov. 10, 2021 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the three and... |
| 07.10.2021 | PolarityTE : Provides Update on Investigational New Drug Application | SALT LAKE CITY, Oct. 7, 2021 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided an update regarding its Investigational New Drug Application (IND) ... |
| 10.03.2021 | PolarityTE to Report Fiscal Year 2020 Financial Results on March 30, 2021 | SALT LAKE CITY--(BUSINESS WIRE)--Mar 10, 2021-- PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the year ended December 31, 2020 by press release on Tuesday, March 30, 2021 at approximately 7:00 a.m. Eastern T... |
| 19.03.2019 | Skin regeneration company PolarityTE reveals SEC investigation, probing into its lead product, former CFO and current investors | Days after publishing in a medical journal a positive case study showcasing its technology that employs a patient’s own healthy tissue to regenerate human skin for the treatment of burns and wounds, PolarityTE has com... |
| - | PolarityTE to Present at the H.C. Wainwright Global Life Sciences Virtual Conference | SALT LAKE CITY--(BUSINESS WIRE)--Mar 2, 2021-- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, announced today that it will present at the H.C. Wainwright Global Life Science... |